Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| AKP Freiburg GmbH | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy.
onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective.
Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| carcinoma, Doce onkovis (Docetaxel) | treatment in mono- or combination therapy with Docetaxel of breast cancer, non-small cell lung cancer, prostata carcinoma, adenocarcinoma of the stomach and advanced squamous cell carcinoma of the head/neck region. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| the quantity of Doce onkovis needed pro treatment cycle | Determine the quantity of Doce onkovis needed pro treatment cycle | the time the participants will be followed depends on the number of treatment cycles; that means the time frame may extend up to 24 weeks (8 cycles). |
| Measure | Description | Time Frame |
|---|---|---|
| adverse events during and after treatment | The number and kind of adverse events during and after the intra-venous application of Docetaxel will be assessed and documented. | up to 24 weeks (8 cycles) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients treated in practices, clinics, hospitals
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Practice | Berlin | 13156 | Germany | |||
| Practice |
Not provided
Not provided
Not provided
Not provided
Not provided
| Brandenburg |
| 14770 |
| Germany |
| Practice | Chemnitz | 09117 | Germany |
| Practice | Cottbus | 03055 | Germany |
| Practice | Dresden | 01307 | Germany |
| Practice | Elstra | 01920 | Germany |
| Practice | Freital | 01705 | Germany |
| Practice | Fürstenwalde | 15517 | Germany |
| Practice | Halle | 06132 | Germany |
| Practice | Köthen | 06366 | Germany |
| Practice | Kronach | 96317 | Germany |
| Hospital | Leipzig | 04277 | Germany |
| Practice | Leipzig | 04277 | Germany |
| Practice | Magdeburg | 39104 | Germany |
| Practice | Meiningen | 98617 | Germany |
| Practice | Mühlhausen | 99974 | Germany |
| Practice | Parchim | 19370 | Germany |
| Practice | Plauen | 08525 | Germany |
| Practice | Scheibenberg | 09481 | Germany |
| Clinic | Torgau | 04860 | Germany |
| Practice | Werdau | 08412 | Germany |
| Practice | Zittau | 02763 | Germany |
| Practice | Zwickau | 08060 | Germany |
| ID | Term |
|---|---|
| D002277 | Carcinoma |
| D001943 | Breast Neoplasms |
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D009371 | Neoplasms by Site |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided